The clinical significance of plasma clusterin and Aβ in the longitudinal follow-up of patients with Alzheimer’s disease
Abstract Background Clusterin and beta-amyloid (Aβ) are involved in the pathogenesis of Alzheimer’s disease (AD). The clinical significance of plasma clusterin and Aβ in AD progression remains controversial. Methods We recruited 322 patients with AD and 88 controls between August 2012 and June 2013....
Main Authors: | Jung-Lung Hsu, Wei-Ju Lee, Yi-Chu Liao, Shuu-Jiun Wang, Jong-Ling Fuh |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-11-01
|
Series: | Alzheimer’s Research & Therapy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13195-017-0319-x |
Similar Items
-
The association of serum clusterin levels and Clusterin rs11136000 polymorphisms with Alzheimer disease in a Turkish cohort
by: Gamze Guven, et al.
Published: (2020-01-01) -
Intraventricular infusion of clusterin ameliorated cognition and pathology in Tg6799 model of Alzheimer’s disease
by: Xue-Mei Qi, et al.
Published: (2018-01-01) -
Plasma clusterin levels and risk of dementia, Alzheimer's disease, and stroke
by: Galit Weinstein, et al.
Published: (2016-01-01) -
Clusterin ameliorates tau pathology in vivo by inhibiting fibril formation
by: Aleksandra M. Wojtas, et al.
Published: (2020-12-01) -
Clinical significance of clusterin expression in pancreatic adenocarcinoma
by: Jin Junshuo, et al.
Published: (2012-07-01)